Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review

2018 ◽  
Vol 39 (2) ◽  
pp. 353-357 ◽  
Author(s):  
Eleftherios Pelechas ◽  
Alexandra Papoudou-Bai ◽  
Paraskevi V. Voulgari ◽  
Alexandros A. Drosos
PEDIATRICS ◽  
1970 ◽  
Vol 45 (3) ◽  
pp. 473-478 ◽  
Author(s):  
John D. Burrington

Subcutaneous nodules, composed of necrotic collagen surrounded by chronic inflammatory cells, occur in about 20% of individuals with rheumatoid arthritis, 10% of those with acute rheumatic fever, and 25% of children with granuloma annulare. Similar subcutaneous lesions indistinguishable from rheumatoid nodules may appear in children who do not develop other stigmata of disease. Mesara and ous lesions of granuloma annulare. Therefore, they felt that, in children, these nodules probably represented a clinical variant of granuloma annulare. Beatty3 described nine children aged 11 days to 9 years with nodules on the scalp, ulnar aspect of the arm, dorsum of the foot, and palm of the hand which appeared histologically to be rheumatoid nodules.


2011 ◽  
Vol 31 (2) ◽  
pp. 385-389 ◽  
Author(s):  
Joaquim Polido-Pereira ◽  
Ana Maria Rodrigues ◽  
Helena Canhão ◽  
Fernando Saraiva ◽  
José Alberto Pereira da Silva ◽  
...  

Author(s):  
Ines Doko Vajdić ◽  
Goran Štimac ◽  
Ivan Pezelj ◽  
Matej Mustapić ◽  
Simeon Grazio

Author(s):  
Carla Isabelly Rodrigues-Fernandes ◽  
Cesar Augusto Migliorati ◽  
Luiz Alcino Monteiro Gueiros ◽  
Thayná Melo de Lima Morais ◽  
Pablo Agustin Vargas ◽  
...  

Author(s):  
Reşit Yıldırım ◽  
Döndü Üsküdar Cansu ◽  
Deniz Arık ◽  
Suzan Saylısoy ◽  
Cengiz Korkmaz

2007 ◽  
Vol 67 (4) ◽  
pp. 567-570 ◽  
Author(s):  
P V Voulgari ◽  
T E Markatseli ◽  
S A Exarchou ◽  
A Zioga ◽  
A A Drosos

Objective:To describe granuloma annulare (GA) skin lesion development in patients during anti-tumour necrosis factor (TNF) therapy.Methods:199 patients with rheumatoid arthritis and 127 suffering from spondyloarthropathies treated with anti-TNF antagonists were analysed to identify skin lesions suggesting GA.Results:Nine cases of GA during anti-TNF therapy (123 treated with infliximab, 57 with adalimumab and 17 with etanercept) for rheumatoid arthritis were identified. Two have been treated with infliximab, six with adalimumab and one with etanercept, and here the development of GA was 4.5%. No patient with spondyloarthropathies developed such skin lesions. All patients developed the generalised form of GA. None had or developed diseases, or conditions known to be associated with GA. In seven patients the skin eruptions developed during the first year of anti-TNF treatment, while they developed in two patients during the second year. Two patients had to stop anti-TNF therapy due to the extent of skin lesions. All patients responded well to the local corticosteroid therapy.Conclusions:Our series strongly supports a link between TNF inhibition and the development of GA in some patients. When dealing with patients on these agents physicians should be aware of possible adverse events and the potential development of such complications.


2021 ◽  
Vol 43 (1) ◽  
pp. 1-5
Author(s):  
Kawther Ben Abdelghani ◽  
Hiba Boussaa ◽  
Houda Lajmi ◽  
Alia Fazaa ◽  
Saoussen Miladi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document